Sophiris Bio Corp: Clinical Trials

1 trial sponsored by Sophiris Bio Corp, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Sophiris Bio Corp: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH
PRX302, Placebo - Benign Prostatic Hyperplasia
Phase 3CompletedSophiris Bio Corp4792013-10-012017-04-27

Conditions studied

Lower Urinary Tract Symptoms (1)  ·  Prostatic Hyperplasia (1)

Interventions

PRX302 (1)

Countries

Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Richard C Yocum, MD (1)